We help people achieve healthy skin Founded more than 100 years, LEO Pharma is an independent, research-based specialty pharma company committed to the discovery and development of novel drugs for patients within dermatology and thrombosis area. LEO Pharma a global leader in dermatology delivers treatment options for psoriasis, actinic keratosis; eczema and skin infections. Also treatment options for thrombosis (blood clots). committed to offer solutions and services to lranian patients to improve their quality of life and help them achieve healthy skin. prepared producing locally its solutions in Iran and share manufacture expertise. to understand customers, engage in partnerships and dialogue.
LEO PHARMA In IRANLEO Pharma is committed to offer their solutions to Iranian patients and helps them achieve healthy skin. LEO PHARMA covers all Middle Eastern countries and has 17 official representative offices in each of these countries, including IRAN. Behestan Behdasht Company which is founded in 2005 in Tehran is LEO PHARMA's official representative in IRAN. LEO Pharma is prepared to locally produce its solutions in IRAN and share its manufacture expertise. LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. LEO Pharma has its own sales forces in 61 countries and employs around 5,000 employees worldwide. The company is headquartered in Denmark and is wholly owned by the LEO Foundation. LEO Pharma's therapeutic focus areas: • Psoriasis • Actinic keratosis and • non-melanoma skin cancer • Eczema • Skin infections • Acne • Skin Rejuvenation • Thrombosis • Cardiovascular • Antibiotics • Coagulation • Osteoporosis • renal care Today, more than 700 scientists and specialists globally work within research and development in LEO Pharma to develop new treatments. LEO PHARMA takes the drugs all the way - from research to registration.
- Location Denmark
- Listing categories HEALTHCARE